Brief: Remus Pharmaceuticals Says Anjali Shah Resigns As CFO
22/06/2026 14:25
BRIEF-Remus Pharmaceuticals Says Anjali Shah Resigns As CFO June 22 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS:
REMUS PHARMACEUTICALS - ANJALI SHAH RESIGNS AS CHIEF FINANCIAL OFFICER EFFECTIVE JULY 8, 2026
Source text: ID:nNSE30NzN4
Further company coverage: REMP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Appoints Bhavik Shah As CFO Effective July 09, 2026
Brief: Remus Pharmaceuticals Says Anjali Shah Resigns As CFO
Brief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings